Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Asset Writedowns and Impairment: 2017-2024

Historic Asset Writedowns and Impairment for cbdMD (YCBD) over the last 2 years, with Sep 2024 value amounting to $921,314.

  • cbdMD's Asset Writedowns and Impairment fell 92.53% to $921,314 in Q3 2024 from the same period last year, while for Sep 2024 it was $26.1 million, marking a year-over-year decrease of 53.32%. This contributed to the annual value of $365,979 for FY2025, which is 60.28% down from last year.
  • Latest data reveals that cbdMD reported Asset Writedowns and Impairment of $921,314 as of Q3 2024, which was down 92.53% from $12.3 million recorded in Q3 2023.
  • In the past 5 years, cbdMD's Asset Writedowns and Impairment registered a high of $30.8 million during Q2 2022, and its lowest value of -$526,628 during Q2 2020.
  • Over the past 3 years, cbdMD's median Asset Writedowns and Impairment value was $12.0 million (recorded in 2022), while the average stood at $11.4 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first plummeted by 124.91% in 2020, then spiked by 1,688.94% in 2022.
  • Quarterly analysis of 5 years shows cbdMD's Asset Writedowns and Impairment stood at -$526,628 in 2020, then reached $18.2 million in 2021, then crashed by 95.13% to $884,892 in 2022, then grew by 2.82% to $12.3 million in 2023, then slumped by 92.53% to $921,314 in 2024.
  • Its Asset Writedowns and Impairment was $921,314 in Q3 2024, compared to $12.3 million in Q3 2023 and $884,892 in Q4 2022.